Introduction
Chondroitin sulfate is a sulfated glycosaminoglycan composed of a long unbranched polysaccharide chain with a repeating disaccharide structure of N-acetylgalactosamine and glucuronic acid [1, 2] . Most of N-acetylgalactosamine residues are sulfated, particularly in the 4 or 6 position, making chondroitin sulfate a strongly charged polyanion with a high water-draining power. Chondroitin 4-sulfate and chondroitin 6-sulfate are often called chondroitin sulfate A (CSA) and chondroitin sulfate C (CSC), respectively. Chondroitin sulfate B (CSB), also known as dermatan sulfate, is a stereoisomeric form of chondroitin sulfate with varying proportions of iduronic acid in place of glucuronic acid [1] [2] [3] . O-Sulfo groups are found on the 4-or 6-position of N-acetylgalactosamine residues or the 2-position of iduronic acid residues of CSB. CSB is often found attached to a protein core, resulting in a macromolecule called a proteoglycan. CSB proteoglycans localize on cell surfaces and in the extracellular matrix and exist excessively in fibrous connective tissues such as skin, tendon, skeletal muscle, blood vessels, bone and cartilage. CSB has been the topic of limited studies in comparison to the more commonly studied glycosaminoglycans such as heparan sulfate, heparin and hyaluronic acid, but recent studies have shown that CSB has intriguing functions in central nervous system development, wound repair, infection, growth factor signaling, morphogenesis and cell division, in addition to its conventional structural roles [3] [4] [5] .
CSB has also been implicated in the pathogenesis of rheumatoid arthritis, a chronic, systemic and inflammatory autoimmune disease of connective tissue. Several changes in glycosaminoglycan expression in synovial tissue and cartilage of rheumatoid arthritis and osteoarthritis patients have been described. In synovial tissue of rheumatoid arthritis patients, CSB has been shown to be the primary molecular species of chondroitin sulfate in inflammatory areas compared with fibrotic areas where CSA/C expression dominates [6] . CSB is the dominant glycosaminoglycan in proteoglycans secreted by synovial cells [7] . Basic activity of the disease and proliferation of the synovial cells correlate with an increased percentage of CSB of the total glycosaminoglycan content in the synovium [8] . Furhtermore, rheumatoid arthritis chondrocytes are known to synthesize an increased proportion of proteoglycans, enriched in CSB [9] . A growing number of pathogens, including viruses, parasites and bacteria, have been shown to use cell-surface chondroitin sulfate and CSB, in addition to heparan sulfate, for their attachment to host cells and tissues [3, 10] . CSB as well as hyaluronic acid has been shown to inhibit an activity of antithrombin, a plasma inhibitor of thrombin [11] . Thrombin plays a key role in enhancing synovial thickness and inflammation during the pathogenesis of rheumatoid arthritis through its cleavage of fibrinogen to form a fibrin clot and its mitogenic effect on synovial cells [12, 13] .
Moreover, in mice, injection of glycosaminoglycans such as CSB, CSA, CSC, and hyaluronic acid has been shown to induce the onset of arthritis, tendosynovitis and dermatitis [14] .
Prompted by the growing evidence of involvement of CSB in the pathogenesis of rheumatoid arthritis, we initiated an examination of the effects of CSB on functions of immune cells infiltrating inflammatory areas. We have recently found that CSB but not CSA or CSC stimulated the polyclonal proliferation of murine B cells as markedly as did anti-IgM antibody and more markedly than did dextran sulfate [15] . Our data suggested that phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) are crucial but that extracellular signal-regulated kinase (ERK) is less important for the mitogenc activity of CSB, the signaling pathways of which may be at least partly distinct from those of anti-IgM and lipopolysaccharide (LPS). Rachmilewitz and Tykocinski reported that CSB stimulated the proliferation of B cells in human peripheral blood mononuclear cells in a monocyte-dependent manner: on depletion of monocytes by adherence to tissue culture flasks, the residual nonadherent cells no 4 longer proliferated when exposed to CSB [16] . Murine splenic B cells, however, responded to CSB independently of adherent cells [15] . Inflammation, infection or physical damage can lead to the release of soluble CSB via degradation of the extracellular matrix in various fibrous connective tissues. Increased soluble CSB may cause polyclonal activation of B cells that could play a role at sites of inflammation and participate in the regulation of autoimmune response. To the best of our knowledge, however, no studies on CSB-induced differentiation of B cells have been reported to date. Since some stimuli which induce proliferation of B cells do not promote or rather inhibit B-cell differentiation [17, 18] , this study was undertaken to examine the effect of CSB on polyclonal antibody production in B cells. Our data indicated that CSB promoted polyclonal differentiation of B cells to antibody-producing cells in the presence of IL-4 and IL-5, and we also obtained evidence that PKC but not PI3K is crucial for CSB-induced IgM production.
Materials and methods

Mice
Female BALB/c mice were purchased from Charles River Japan (Yokohama, Japan). They were maintained under specific pathogen-free conditions in the animal facility of Okayama University and used between 8 and 12 weeks of age.
Reagents and antibodies
CSB sodium salt (porcine intestinal mucosa), heparin sodium salt (porcine intestinal mucosa), hyaluronic acid (bovine vitreous humor), dextran sulfate sodium salt, LPS from Escherichia coli 055:B5, and propidium iodide were obtained from Sigma 
Preparation of enriched B cells
Murine spleen resting conventional (CD5 
Antibody response of enriched B cells
Enriched B cells were first incubated with or without CSB in the basal culture medium (RPMI 1640 medium, supplemented with 10% heat-inactivated fetal calf serum, 2 mM L-glutamine, 100 U/ml of penicillin G and 100 μg/ml of streptomycin) in the . The IgM levels were assayed by a sandwich ELISA as described previously [19] . The number of viable cells was determined by a Trypan Blue dye-exclusion test.
Enzyme-linked immunospot (ELISPOT) assay for detection of polyclonal
IgM-secreting cells
Detection of IgM-secreting cells was carried out as decribed by Sedgwick and
Holt [20] and by Hodgkin et al. [21] . Briefly, each well of 96-well microtiter plates was 
Flow cytometric analysis of cell surface antigen expression
Enriched B cells were incubated with or without CSB in the basal culture medium FITC-conjugated anti-mouse CD45R/B220 mAb (10 μg/ml) or PE-conjugated rat anti-mouse CD138 mAb (4 μg/ml) for 30 min on ice. After being washed with and suspended in PBS containing 0.5% bovine serum albumin and 0.1% sodium azide, the cells were stained with propidium iodide (2 μg/ml), and expression of CD45R/B220 and CD138 on viable cells was analyzed by a flow cytometer (Epics XL, Beckman Coulter). harvested on glass fiber filters using a cell harvester as described previously [15] . The amount of [ 3 H]thymidine incorporated was measured in a liquid scintillation counter.
Determination of DNA synthesis
Determination of cytokine production
Enriched B cells (2. 
Results
The mitogenic effect of CSB on IL-4-and IL-5-stimulated B cells
We have recently reported that CSB alone markedly stimulated proliferation of murine B cells in a basal culture medium [15] . h. CSB stimulated DNA synthesis of B cells, and its dose-response curve was nearly linear up to 100 μg/ml (Fig. 1A) . The number of viable cells in 72-h culture was dose-dependently increased by CSB, being a 50% increase over the control at 100 μg/ml of CSB (Fig. 1B) .
Augmentation of IgM production in B cells by CSB and effects of other glycosaminoglycans
Those cells stimulated with or without varying doses of CSB for 72 h as described above were then washed and recultured without CSB in the presence of IL-4
and IL-5 for 4 days at an initial density of 1 × 10 5 cells/well. IgM produced was determined by an ELISA, and the results are shown in Fig. 2A . CSB dose-dependently increased IgM production, and its stimulatory effect reached a plateau at 6.3 μg/ml with maximal enhancement of 450%. The maximal effect of CSB was comparable to that of 0.1 μg/ml of LPS ( Fig. 2A) . Since CSB was omitted during the reculture period, the viable cell density in the treated cultures did not significantly differ from that of the control cultures at the end of the reculture period (Fig. 2B ). CSB obtained from Celsus
Laboratories was as effective as CSB from Sigma Chemical Company (data not shown).
IgG production was also markedly increased by CSB, although the levels of IgG were less than one fourth of IgM levels in the same culture at any doses of CSB (data not shown). Figure 2C but not that of CSB was potently inhibited by polymyxin B (Fig. 2D) . The effects of other glycosaminoglycans and dextran sulfate on IgM production in B cells are shown in Fig. 3 . Dextran sulfate was as effective as CSB, but CSA, CSC, heparin, and hyaluronic acid were marginally effective or ineffective.
CSB-induced differentiation of B cells
The number of antibody-secreting cells in cultures treated with or without CSB for 2.5 days in the reculture period was determined by the ELISPOT assay, and the results were expressed as the number of spots per 10 5 viable cells. Treatment with 6.3, 25, and 100 μg/ml of CSB in the presenc of IL-4 and IL-5 resulted in a more than 400% increase in the number of IgM-secreting cells, similar to the effect of 0.1 μg/ml of LPS (Fig. 4A) . The number of antibody-secreting cells in cultures incubated without IL-4
and IL-5 was also significantly enhanced by CSB, although the absolute values were much lower than those in B cells incubated with IL-4 and IL-5 (Fig. 4B) . B cells activated with CSB in the absence of IL-4 and IL-5 produced an increased amout of
IL-12 but not IL-4 and, in contrast to B cells stimulated with LPS, TNF-α (data not shown). It is known that differentiation of naive B cells to plasma cells is accompanied
by an increase in CD138 expression and by a decrease in CD45R/B220 expression [22, 23] . B cells treated with or without CSB or LPS for 2.5 days in the second culture were subjected to analyses of expression of both cell-surface antigens by a flow cytometer. Both CSB and LPS significantly increased the percent of CD138-positive cells and the percent of CD45R/B220-negative cells (Fig. 5A−D) .
Requirement of PKC but not PI3K in CSB-induced IgM production
We have recently shown that CSB caused translocation of PKC isoform β from cytosol to membrane fractions and increased phosphorylation of Akt but not phosphorylation of ERK of B cells and that PI3K and PKC are crucial but that ERK is less important for the B cell mitogenc activity of CSB [15] . In order to elucidate the role of those signaling pathways in CSB-induced differentiation of B cells, we conducted experiments using pharmacological inhibitors, and the results are shown in Fig. 6 .
When the inhibitors were included in the first culture period only, CSB-induced IgM production was potently inhibited by the PKC inhibitor GF109203X (1 μM) but not by the PI3K inhibitor wortmannin (100 nM) (Fig. 6A) . In contrast, the mitogen-activated protein/ERK kinase (MEK) inhibitor PD98059 (12.5 μM) significantly enhanced IgM production promoted by CSB. On the other hand, LPS-induced IgM production was partially inhibited by GF109203X but not by either wortmannin or PD98059. Similar results were obtained when each inhibitor was added to cultures during both the first culture and reculture periods (Fig. 6C ), but none of the three inhibitors had any effect when they were included during the reculture period only (Fig. 6B) .
Discussion
The results presented in this paper demonstrated that CSB markedly induced for the maximal differentiation-inducing effect of CSB determined by this method was much less than the concentration required for the maximal mitogenic effect of CSB: the stimulatory effect of CSB on IgM production was maximal at 6.3 μg/ml, whereas its mitogenic effect was linealy increased up to 100 μg/ml (Fig. 1A and Fig. 2A) . Since the addition of 6.3 μg/ml of CSB resulted in a 30% increase in the number of valiable cells during the primary culture for 3 days (Fig. 1B) , overall IgM production in the 13 CSB-treated cultures was calculated to be seven-times greater than the IgM production in untreated cultures. Rafi et al. reported that stimulation of B cells with 0.1 and 0.5 mg/ml of hyaluronic acid resulted in 80% and 120% increases in IgM production, respectively [24] . However, in our two-step culture system hyaluronic acid was marginally effective but CSB markedly effective at 6.3 μg/ml. Thus CSB is a stronger differentiation-promoting agent than hyaluronic acid. Inflammation, infection or injury can lead to the release of soluble CSB via degradation of the extracellular matrix, and CSB comprises over half of the total soluble glycosaminoglycan content of wound fluid [25] . Increased soluble CSB may cause polyclonal activation and proliferation of B cells in the earlier phase, and in the later phase, increased B cells may produce a large amount of polyclonal antibody even at reduced or null concentrations of CSB.
Several lines of evidence suggest that CSB is involved in the pathogenesis of rheumatoid arthritis, an autoimmune disease of connective tissue. CSB is the dominant glycosaminoglycan in proteoglycans secreted by synovial cells [7] . Basic activity of the disease and proliferation of the synovial cells correlate with an increased percentage of CSB of the total glycosaminoglycan content in the synovium [8] . Furhtermore, rheumatoid arthritis chondrocytes are known to synthesize an increased proportion of proteoglycans, enriched in CSB [9] . A growing number of pathogens, including viruses, parasites and bacteria, have been shown to use cell-surface CS and CSB, in addition to heparan sulfate, for their attachment to host cells and tissues [3, 10] . In mice, injection of glycosaminoglycans such as CSB, CSA, CSC, and hyaluronic acid has been shown to induce the onset of arthritis, tendosynovitis and dermatitis [14] . Our data showing CSB-induced polyclonal proliferation and differentiation of B cells further support the notion that CSB plays a role at sites of inflammation and participates in the regulation of autoimmune response.
Our previous results using specific pharmacological inhibitors of protein kinases suggest a role of PKC and PI3K in the proliferation of B cells induced by CSB [15] .
Evidence for an essential role of PKC and PI3K in BCR signal transduction has been provided by various studies. B cells of mice deficient in PKCβ have been shown to exhibit a defective proliferative response to anti-IgM antibody, despite normal T-cell activation in response to T cell receptor stimulation [26] . B cells of mice deficient in the p85α or p85α-p55α-p50α adaptor proteins of PI3K had diminished proliferative responses to both anti-IgM antibody and LPS [27, 28] , although mice deficient in p110δ
catalytic subunit had a poor B cell response to anti-IgM antibody but a normal response to LPS [29] . IgM production induced by CSB, however, was inhibited by the PKC inhibitor but not by the PI3K inhibitor, indicating that the proliferation and Hence it is not known at present whether or not PKC is involved in the regulation of expression of the both transcription factors. In contrast to the PKC inhibitor, the MEK inhibitor enhanced IgM production promoted by CSB. It has been shown that continuous BCR signaling through the Ras-MEK-ERK pathway inhibits LPS-induced plasma cell differentiation [31] , but neither CSB nor IL-4 increased phosphorylation of ERK [15, 32] . Thus, the mechanism responsible for augmentation of CSB-induced IgM production in B cells treated with the MEK inhibitor remains to be investigated.
CSB has been shown to interact with CD44, a broadly distributed cell surface protein, although the interaction of CD44 with CSB is more modest than that of CD44 with hyaluronic acid [33] . CD44 is an adhesion molecule with known importance in T cell activation, lymphocyte trafficking and tumor cell invasiveness [2, 34] . Moreover, some studies have suggested that CD44 participates in the activation of monocytes and B cells induced by hyaluronic acid, CSA, CSB or chondroitin sulfate proteoglycans [16, 24, 35] . The involvement of CD44 in the mitogenic and differentiation-inducing effects of CSB on murine B cells remains to be determined, although CD44 expression in murine B cells increases when B cells are activated with polyclonal stimuli, including LPS and interleukin 5 [36] , and CD40 ligand-induced B cell proliferation and immunoglobulin production are inhibited by immobilized anti-CD44 mAbs [37] .
In conclusion, the results of this study demonstrated that CSB promoted polyclonal differentiation of B cells to antibody-secreting cells in the presence of IL-4
and IL-5 at doses less than those required for the mitogenic effect, and the results suggest that PKC but not PI3K is crucial for CSB-induced IgM production. Our data further support the notion that CSB plays a role in the regulation of autoimmune response. 22
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